Potassium bromide for treatment of malignant migrating partial seizures in infancy

Area of Science:

• Pediatric Neurology
• Epileptology
• Pharmacology

Background:

• Malignant migrating partial seizures in infancy is a rare, severe epileptic syndrome.
• Characterized by early-onset, multifocal, pharmacoresistant seizures from multiple brain sites.
• Etiology remains largely unknown, posing treatment challenges.

Observation:

• A 2-month-old infant presented with characteristic clinical and EEG patterns of this syndrome.
• The infant's seizures were refractory to conventional and newer antiepileptic drugs.
• Treatment with potassium bromide was initiated.

Findings:

• Potassium bromide markedly reduced seizure frequency in the infant.
• Demonstrated efficacy in a case resistant to multiple other antiepileptic therapies.
• Potassium bromide proved beneficial for this specific epilepsy syndrome.

Implications:

• Potassium bromide, an established antiepileptic drug, shows promise for treating malignant migrating partial seizures in infancy.
• Suggests a potential role for older antiepileptic medications in managing refractory epilepsy syndromes.
• Highlights the need for exploring diverse therapeutic avenues for rare and severe pediatric epilepsy conditions.